(MUV2) Münchener Rück - Ratings and Ratios
Reinsurance, Life, Health, Property, Casualty
MUV2 EPS (Earnings per Share)
MUV2 Revenue
Description: MUV2 Münchener Rück
Münchener Rückversicherungs-Gesellschaft AG (MUV2) is a Munich-based global insurer and reinsurer operating through five distinct segments: Life & Health Reinsurance, Property-Casualty Reinsurance, ERGO Life & Health Germany, ERGO Property-Casualty Germany, and ERGO International.
The firm delivers a wide-range of solutions, from digital underwriting, advanced analytics, and health-insurance management systems to specialty reinsurance lines such as agricultural, cyber, and aviation. Its digital suite (MIRA PoS, MIRApply, CLARA plus) and data-analytics platforms (REALYTIX ZERO, cert2go) support both corporate and consumer-facing products under the ERGO brand, including legal protection, travel, and renewable-energy insurance.
According to its 2023 annual report, Münchener Rück generated €5.4 billion in net profit, achieved a combined ratio of 93.5 % in property-casualty reinsurance, and posted a return on equity (ROE) of 12.8 %, reflecting strong underwriting discipline and capital efficiency.
Key drivers for the business include persistent low-interest-rate environments that pressure investment income, heightened climate-change exposure driving demand for NatCat and parametric solutions, and accelerating cyber-risk frequency prompting growth in cyber-reinsurance and related analytics services.
If you’re looking to deepen your quantitative assessment, a look at ValueRay’s sector-level risk models could provide useful context for MUV2’s valuation dynamics.
MUV2 Stock Overview
| Market Cap in USD | 85,601m |
| Sub-Industry | Reinsurance |
| IPO / Inception |
MUV2 Stock Ratings
| Growth Rating | 83.5% |
| Fundamental | 64.2% |
| Dividend Rating | 77.5% |
| Return 12m vs S&P 500 | -1.57% |
| Analyst Rating | - |
MUV2 Dividends
| Dividend Yield 12m | 3.62% |
| Yield on Cost 5y | 11.42% |
| Annual Growth 5y | 11.23% |
| Payout Consistency | 98.9% |
| Payout Ratio | 51.5% |
MUV2 Growth Ratios
| Growth Correlation 3m | -46.6% |
| Growth Correlation 12m | 66.3% |
| Growth Correlation 5y | 95.7% |
| CAGR 5y | 30.38% |
| CAGR/Max DD 3y (Calmar Ratio) | 2.00 |
| CAGR/Mean DD 3y (Pain Ratio) | 10.20 |
| Sharpe Ratio 12m | -0.17 |
| Alpha | 3.32 |
| Beta | 0.574 |
| Volatility | 19.93% |
| Current Volume | 295.8k |
| Average Volume 20d | 223.7k |
| Stop Loss | 535.6 (-3%) |
| Signal | -0.41 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (5.09b TTM) > 0 and > 6% of Revenue (6% = 3.85b TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 0.16pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1.56% (prev 32.58%; Δ -34.14pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 3.14b <= Net Income 5.09b (YES >=105%, WARN >=100%) |
| Net Debt (786.0m) to EBITDA (7.89b) ratio: 0.10 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.86 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (130.3m) change vs 12m ago -2.43% (target <= -2.0% for YES) |
| Gross Margin 98.12% (prev 94.11%; Δ 4.01pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 23.27% (prev 23.12%; Δ 0.14pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 20.72 (EBITDA TTM 7.89b / Interest Expense TTM 348.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.58
| (A) -0.00 = (Total Current Assets 6.12b - Total Current Liabilities 7.12b) / Total Assets 275.69b |
| (B) 0.09 = Retained Earnings (Balance) 24.53b / Total Assets 275.69b |
| (C) 0.03 = EBIT TTM 7.21b / Avg Total Assets 275.87b |
| (D) 0.13 = Book Value of Equity 31.96b / Total Liabilities 244.93b |
| Total Rating: 0.58 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 64.18
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield -2.91% = -1.45 |
| 3. FCF Margin 4.40% = 1.10 |
| 4. Debt/Equity 0.20 = 2.48 |
| 5. Debt/Ebitda 0.10 = 2.49 |
| 6. ROIC - WACC (= 6.21)% = 7.76 |
| 7. RoE 15.95% = 1.33 |
| 8. Rev. Trend -34.37% = -2.58 |
| 9. EPS Trend 40.95% = 2.05 |
What is the price of MUV2 shares?
Over the past week, the price has changed by -2.47%, over one month by +7.14%, over three months by -3.09% and over the past year by +13.03%.
Is Münchener Rück a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MUV2 is around 629.50 EUR . This means that MUV2 is currently undervalued and has a potential upside of +14% (Margin of Safety).
Is MUV2 a buy, sell or hold?
What are the forecasts/targets for the MUV2 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 560.1 | 1.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 696 | 26% |
MUV2 Fundamental Data Overview
Market Cap EUR = 73.38b (73.38b EUR * 1.0 EUR.EUR)
P/E Trailing = 14.4255
P/E Forward = 11.2867
P/S = 1.1774
P/B = 2.3392
P/EG = 0.4129
Beta = 0.574
Revenue TTM = 64.19b EUR
EBIT TTM = 7.21b EUR
EBITDA TTM = 7.89b EUR
Long Term Debt = 6.11b EUR (from longTermDebt, last quarter)
Short Term Debt = 213.0m EUR (from shortTermDebt, last fiscal year)
Debt = 6.11b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 786.0m EUR (from netDebt column, last quarter)
Enterprise Value = -97.21b EUR (73.38b + Debt 6.11b - CCE 176.70b)
Interest Coverage Ratio = 20.72 (Ebit TTM 7.21b / Interest Expense TTM 348.0m)
FCF Yield = -2.91% (FCF TTM 2.83b / Enterprise Value -97.21b)
FCF Margin = 4.40% (FCF TTM 2.83b / Revenue TTM 64.19b)
Net Margin = 7.93% (Net Income TTM 5.09b / Revenue TTM 64.19b)
Gross Margin = 98.12% ((Revenue TTM 64.19b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 100.0%)
Tobins Q-Ratio = -0.35 (set to none) (Enterprise Value -97.21b / Total Assets 275.69b)
Interest Expense / Debt = 0.90% (Interest Expense 55.0m / Debt 6.11b)
Taxrate = 27.15% (777.0m / 2.86b)
NOPAT = 5.25b (EBIT 7.21b * (1 - 27.15%))
Current Ratio = 0.86 (Total Current Assets 6.12b / Total Current Liabilities 7.12b)
Debt / Equity = 0.20 (Debt 6.11b / totalStockholderEquity, last quarter 30.58b)
Debt / EBITDA = 0.10 (Net Debt 786.0m / EBITDA 7.89b)
Debt / FCF = 0.28 (Net Debt 786.0m / FCF TTM 2.83b)
Total Stockholder Equity = 31.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.85% (Net Income 5.09b / Total Assets 275.69b)
RoE = 15.95% (Net Income TTM 5.09b / Total Stockholder Equity 31.92b)
RoCE = 18.96% (EBIT 7.21b / Capital Employed (Equity 31.92b + L.T.Debt 6.11b))
RoIC = 13.77% (NOPAT 5.25b / Invested Capital 38.16b)
WACC = 7.56% (E(73.38b)/V(79.49b) * Re(8.13%) + D(6.11b)/V(79.49b) * Rd(0.90%) * (1-Tc(0.27)))
Discount Rate = 8.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.59%
[DCF Debug] Terminal Value 74.78% ; FCFE base≈2.65b ; Y1≈2.19b ; Y5≈1.57b
Fair Price DCF = 220.6 (DCF Value 28.59b / Shares Outstanding 129.6m; 5y FCF grow -21.22% → 3.0% )
EPS Correlation: 40.95 | EPS CAGR: 68.60% | SUE: 1.31 | # QB: 1
Revenue Correlation: -34.37 | Revenue CAGR: -4.25% | SUE: -0.88 | # QB: 0